Literature DB >> 34151295

Protocols for analysis of mitochondrial permeability transition pore opening in mouse somatic cell reprogramming.

Zhongfu Ying1,2, Zihuang Liu1,2, Ge Xiang1,2, Yanmin Xin1,2, Junwei Wang1,2, Xingguo Liu1,2,3.   

Abstract

Somatic cells can be reprogrammed into induced pluripotent stem cells (iPSCs) by defined factors. Here, we describe a protocol for imaging mitochondrial permeability transition pore (mPTP) opening in reprogramming of somatic cells using a confocal microscope. We also describe a method to sort high and low mPTP opening somatic cells by calcein fluorescence and reprogram these sorted cells to iPSCs. These protocols are also suitable for imaging mPTP opening and uncovering the mechanisms of mPTP function in other cell fate conversions. For complete details on the use and execution of this protocol, please refer to Ying et al. (2018).
© 2021 The Author(s).

Entities:  

Keywords:  Cell Biology; Cell-based Assays; Flow Cytometry/Mass Cytometry; Metabolism; Microscopy; Stem Cells

Mesh:

Substances:

Year:  2021        PMID: 34151295      PMCID: PMC8188620          DOI: 10.1016/j.xpro.2021.100568

Source DB:  PubMed          Journal:  STAR Protoc        ISSN: 2666-1667


Before you begin

Prepare medium

Timing: [20–30 min] Prepare fibroblast medium and mouse embryonic stem cells (mES) medium. Fibroblast medium Mouse embryonic stem cells (mES) medium Fibroblast medium should be stored at 4°C and used within one month. The mES medium contains LIF, so it should be stored at 4°C and used within two weeks.

Prepare buffer and solution

Timing: [2–3 h] Prepare Modified HBSS Buffer and Polyethylenimine (PEI) solution.

Modified HBSS buffer

Modified HBSS is purchased from ThermoFisher (Thermo Fisher Scientific, 14175095). Compare with HBSS, it has glucose without calcium, magnesium and phenol red.

PEI solution (1 mg/mL)

Add 100 mg PEI (Polysciences, 23966) to 100 mL ddH2O. Heat the solution to 65°C–70°C for 5 min. Add 1 M HCl to adjust pH to neutral (6.8–7.2). Sterilize the solution using Millipore’s 0.22 μm Steriflip filter. Prepare 100 × 1 mL aliquots and store them at −20°C until use. Avoid repeated freezing and thawing. After thawing, it can be stored at 4°C for 3–4 weeks. ddH2O is 18.2 Ω MilliQ sterilized H2O. CRITICAL: The pH of solution needs to be adjust to neutral (6.8–7.2) or it will affect the transfection efficiency.

Prepare cells

Timing: [5–7 days] Prepare Plat-E cells, Mouse embryonic fibroblasts and reprogramming cells. Plat-E cells were cultured in fibroblast medium and used to package the retroviruses. Mouse embryonic fibroblasts (MEFs) were derived from 13.5-day mouse embryos carrying a transgenic Oct4 promoter driving GFP expression and cultured in fibroblast medium. Before MEFs successfully reprogram into induced pluripotent stem cells (iPSCs), the GFP will not express. In our reprogramming system the iPSCs appeared at least at day 15. In our analysis, the reprogrammed cells were all at early stage of reprogramming process and had no GFP expression. MEFs were used at passage 2. Prepare reprogramming cells. After medium was removed, MEFs were infected with retroviruses. After 24 h the retroviruses were removed and added new retroviruses for another 24 h and the cells were cultured in mES medium after viral supernatants were removed. The day that viral supernatants were removed was defined as day 0. mPTP opening was detected by using the calcein release assay at days 0, 3, 5 and 8.

Prepare viruses

Timing: [2–3 days] Retroviruses plasmid transfection. Retroviruses were packaged by transfection of Plat-E cells with pMXs retroviral vectors containing the coding sequences of mouse Sox2, Klf4, Oct4 and c-Myc (SKOM, Yamanaka’s factors). The plasmids vectors were transfected by using polyethyleneimine (PEI) -mediated transfection. This process needs 12-13 h. The Plat-E cells were incubated at 40% density to 100-mm dish 24 h before transfection. Before transfection, replace the fibroblast medium with 10 mL fresh medium. Prepare DNA-PEI complex: Plasmids vectors were diluted into Optimized Medium (Gibco, 31985-070), mixed well, incubated at around 25°C for 5 min. PEI was added into the Optimized Medium containing plasmids, mixed well, incubated at around 25°C for 8–15 min. The reagent volumes are shown in Table 1.
Table 1

Reagent volumes

Culture vesselPlasmidsPEI (1 mg/mL)Optimized medium
100-mm dish10 μg/dish40 μL1000 μL
Reagent volumes Drop the Optimized Medium with DNA: PEI complex to the cells, and shake the dish gently to make the complex distribute evenly. CRITICAL: Adding DNA: PEI complex to the cells needs to be done slowly and drop by drop to make the complex distribute evenly. If the distribution of the complex is not even, the transfection efficiency will be seriously affected. Replace fibroblast medium with 10 mL fresh medium at 12 h after plasmid transfection. Retroviruses collection. This process needs two days. Viral supernatants are collected at 48 h after plasmid transfection. Add fresh fibroblast medium and collect viral supernatants 24 h later. Mix these viral supernatants. Filter the viral supernatants with 0.45 μm Steriflip filter. Pause point: Viral supernatants can be stored up to 7 days at 4°C.

Key resources table

Step-by-step method details

Detecting the opening of mPTP in reprogramming cells

Prepare reprogramming cells

Timing: [3 days] Coat 35 mm dish Glass-bottom dishes have poor adhesion for cells. Coating dishes with gelatin (EmbryoMax 0.1% Gelatin Solution) can enhance MEF cells adhesion. Coat 35 mm dish with 1 mL gelatin for at least 0.5 h at 37°C. Split MEFs Remove the gelatin and plate MEFs at 40,000 cells per dish. Gently put the dish into a 37°C, 5% CO2 incubator for 24 h for cell attachment. CRITICAL: MEFs are likely to aggregate. Cells should be evenly distributed to facilitate viral infection, which is important for reprogramming. MEFs are likely to aggregate in the gelatin-coated dish, so the cells should be diluted to an appropriate amount before plating. For 35 mm dish, appropriate number of cells was diluted to 1 mL culture medium and mixed well. Add the cells into dish and gently rock the dish to distribute the cells. The proliferation rate of MEFs varies among different batches of mouse. We need to prepare 160,000 MEFs to repeat this experiment with appropriate cell confluence. The 30%–40% confluence of the initial cells will be hard for us to image at day 8 because of the rapid emergence of clones (Figure 1). So we need to prepare appropriate cell number in each dish and don’t plate more than 40,000 cells per dish.
Figure 1

Calcein release assay

(A) The morphological change occurs during reprogramming. The amount of cells is appropriate (Day 8-a) compared with too many ones, which form clones (Day 8-b). Scale bar corresponds to 100 μm.

(B) Opening of mPTP was analyzed at days 0, 3, 5, and 8 during reprogramming. Scale bar corresponds to 20 μm.

Infect MEFs with SKOM retroviruses Calcein release assay (A) The morphological change occurs during reprogramming. The amount of cells is appropriate (Day 8-a) compared with too many ones, which form clones (Day 8-b). Scale bar corresponds to 100 μm. (B) Opening of mPTP was analyzed at days 0, 3, 5, and 8 during reprogramming. Scale bar corresponds to 20 μm. Remove the medium and add 2.5 mL SKOM viral supernatants to dish with 24 h incubation and infect two rounds (24 h each round).

Calcein release assay

Timing: [30–45 min] This assay employs calcein-AM, a colorless and nonfluorescent esterase substrate, and CoCl2, a quencher of calcein fluorescence, to selectively label mitochondria. Cells are loaded with the acetoxymethyl ester of calcein dye, calcein-AM, which passively diffuses into the cells and accumulates in cytosolic compartments, including the mitochondria. Once inside cells, intracellular esterases cleave the acetoxymethyl esters to liberate the very polar fluorescent dye calcein, which does not cross the mitochondrial or plasma membranes in appreciable amounts over relatively short periods of time. The fluorescence from cytosolic calcein is quenched by the addition of CoCl2, while the fluorescence from the mitochondrial calcein is maintained. When mPTP is open, more CoCl2 will go into mitochondria and quench calcein. The calcein fluorescence intensity indicates the opening of mPTP. Wash cells twice with modified HBSS buffer. Incubate cells in 1 mL labeling solution for 15 min protected from light at 37°C. Labeling solution Labeling solution must be used immediately After incubation, cells were washed with 1 mL warm modified HBSS buffer for once to remove residual dye and minimize background. Calcein release assay was carried out according to manufacturer’s instructions (https://www.thermofisher.com/document-connect/document-connect.html?url=https%3A%2F%2Fassets.thermofisher.com%2FTFS-Assets%2FLSG%2Fmanuals%2Fmp35103.pdf&title=SW1hZ2UtaVQgTElWRSBNaXRvY2hvbmRyaWFsIFRyYW5zaXRpb24gUG9yZSBBc3NheSBLaXQ=) in Transition Pore Assay Kit. The hoechst and CoCl2 were stock solution in the Kit, we need to prepare the stock solution of calcein-AM (1 mM) with DMSO. Prepare labeling solution with these stock solutions and label cells for imaging as described at step 5.

Confocal imaging

Timing: [2 h/day] Image cells with Zeiss LSM710 (Calcein: Ex 488 and Emi 509; DAPI: Ex 405 and Emi 420) and find the reprogramming cells. At day 0, the reprogramming just begin and we can't select which cell will undergo reprogramming, so we image the cells at random. The cells will go through MET (mesenchymal - epithelial transition) during reprogramming (Li et al., 2010) and we found the cells begin undergoing epithelial-like morphological change from elongated cells to rounded cells at day 3 in our system (Ying et al., 2016 and Figure 1A). So image the morphology changed cells which are reprogramming cells at days 3, 5 and 8 during reprogramming process as shown in Figure 1A. Prepare four dishes and the mPTP opening analysis was carried out at days 0, 3, 5 and 8 during reprogramming as shown in Figure 1B. In our system, the day that viral supernatants were removed was defined as day 0. Most confocal microscopes can image mPTP opening, such as Zeiss LSM 880 or Leica DMIRE2 inverted microscope.

Sorting high and low mPTP opening cells

Culture MEFs

Timing: [2–3 days] After quickly thawing MEFs in a 37°C water bath, immediately transfer the thawed cell into a 15 mL tube containing 5 mL of fibroblast medium. Centrifuge the tube for 5 min at 200 g. Discard the supernatant and transfer the cell to a 10 cm dish with 10 mL fibroblast medium and go to the next step at 2–3 days till the number of cells reach to 3–6 million (the confluence reaches to 60%–80%).

Stain MEFs

Timing: [45–60 min] Use 1 mL DPBS to wash cells once and add 1 mL 0.25% Trypsin-EDTA at 37°C for 2 min. Add 1 mL fibroblast medium, suspend MEFs and centrifuge for 5 min at 200 g. Suspend MEFs with modified HBSS buffer (Negative control, NC) or labeling solution without hoechst (modified HBSS buffer with 1 μM calcein and 1 mM CoCl2) at a final concentration of 1 × 106 cells/mL and incubate for 15 min protected from light at 37°C. The negative control is used to set up the MoFlo Astrios instrument with appropriate photomultiplier tubes (PMT) voltages refer to the guidelines for the use of flow cytometry (Cossarizza et al., 2019). After incubation, labeled cells were washed with 1 mL modified HBSS buffer and centrifuged for 5 min at 200 g and washed for twice to remove residual dye and minimize fluorescent background.

Sort the high and low mPTP opening cells

Timing: [2–4 h] Resuspend MEFs to 2% BSA in DPBS buffer and sort the mPTP opening cells according to calcein fluorescence intensity. Before sorting, we need to prepare the tubes with medium to collect the sorted cells. We also need to prepare the gelatin-coated 12-well plate for cell attachment after the sorting. CRITICAL: The 12-well plate must be coated with gelatin otherwise many cells will die. Set the sorting parameters of flow cytometry with 488 nm excitation. We first gate the appropriate cells with signal cells and without debris (gate R1 and R2) and go to G2. And then in G2 we gate the low (R3) and high (R4) calcein fluorescence intensity cells (mean fluorescence intensity of high is about 10 times more than that of low) (Figure 2).
Figure 2

The sorting parameters of flow cytometry

We first gate the appropriate cells with signal cells and without debris (gate R1 and R2) and go to G2. And then in G2 we gate the low (R3) and high (R4) calcein fluorescence intensity cells.

The sorting parameters of flow cytometry We first gate the appropriate cells with signal cells and without debris (gate R1 and R2) and go to G2. And then in G2 we gate the low (R3) and high (R4) calcein fluorescence intensity cells. Sort the cells with low and high calcein fluorescence intensity indicating high and low mPTP opening, respectively.

Perform the reprogramming

Timing: [18 days] Plate high and low mPTP opening cells to 12-well plate and incubate for 12 h for cell attachment. Infect the cells with SKOM retroviruses as described previous (In Prepare Viruses section and Prepare Cells section of Reprogramming cells) Count the efficiency of reprogramming at day 15. The reprogramming efficiency was determined by counting GFP-positive iPSC colonies.

Expected outcomes

Mitochondrial permeability transition pore (mPTP) is permeable to any molecule of <1.5 kDa in size. Its prolonged opening results in cell death. Transient mPTP opening has physiological roles unrelated to death stimuli, such as Ca2+ release and redox equilibrium (Rasola and Bernardi, 2007). Here we image the transient opening of mPTP during reprogramming which may play a physiological role in reprogramming. If we find the changes of mPTP status in reprogramming, it may indicate that mPTP has physiological function in the conversion of somatic cells into pluripotent ones. Following this protocol, we developed a method for analysis of mPTP opening during reprogramming and another method of sorting the high and low mPTP opening cells for reprogramming. Too many the initial cells will result in formation of clones at day 8 during reprogramming (Figure 1A). With appropriate cells, the result showed that opening of the mPTP increased at day 3, then decreased at day 5 and maintained at that level at day 8 (Figure 1B). The MEFs could be sorted by low and high mPTP opening through flow cytometry with the calcein fluorescence intensity (Figure 2). In other cells fate conversion, these protocols are also suitable. With these methods we could analyze the status of mPTP at different stage of cells fate conversion and uncover the mechanisms of mPTP function.

Limitations

Our protocol is designed for reprogramming cells. In our system, we need to select the reprogramming cells and these cells are easy to form clones during the reprogramming, which need to be taken into consideration for mPTP opening analysis. We don't think in other cell lines or primary cells will have these problems, and you don’t need to follow our protocol completely. The manufacturer’s instructions (https://www.thermofisher.com/document-connect/document-connect.html?url=https%3A%2F%2Fassets.thermofisher.com%2FTFS-Assets%2FLSG%2F manuals%2Fmp35103.pdf&title=SW1hZ2UtaVQgTElWRSBNaXRvY2hvbmRyaWFsIFRyYW5zaXRpb24gUG9yZSBBc3NheSBLaXQ=) in Transition Pore Assay Kit is enough for analysis. In our protocol, the MEFs were derived from 13.5-day mouse embryos carrying a transgenic Oct4 promoter driving GFP expression. If there is no access to this mice, Alkaline phosphatase (AP) staining of cells or FACS analysis of SSEA1-positive cells at day 15 of reprogramming are also the ways to indicate the efficiency of reprogramming. Alkaline phosphatase staining could be performed with NBT/BCIP (Roche, 11697471001). The cell surface marker SSEA1 can also be used to detect the reprogramming cells. Cells were incubated with anti-mouse SSEA1 PE (eBioscience, 50-8813-41) and analyzed on a FACS Aria (BD Biosciences). These two methods can indicate the efficiency of reprogramming, however not all of AP and SSEA1 positive cells can be converted into induced pluripotent stem cells (iPSCs). Hu and colleagues have used both above-mentioned methods to uncover certain mechanisms for reprogramming (Hu et al., 2014). However, it is important to note that Oct4-GFP fluorescence is easy, accurate and stable for detecting the efficiency of reprogramming.

Troubleshooting

Problem 1

Mesenchymal-to-epithelial transition doesn't appear at day3 during reprogramming (step 7)

Potential solution

There are two reasons about this problem. 1) The infection efficiency of SKOM retroviruses is low and the reprogramming failed; 2) The dish is coated with too little gelatin or the coating time is not enough, which result in poor adhesion of cells. We need to improve the infection efficiency of retroviruses and increase the amount of gelatin and the coating time.

Problem 2

The calcein fluorescence intensity is low or hard to detect (steps 4–7 and 10–14) Stock solution of calcein-AM (1 mM) may be expired. The stock solution should not be stored at −4°C for more than 2 weeks.

Problem 3

The calcein fluorescence diffuses in cells other than mitochondria or there is calcein fluorescence in cytosolic area (steps 4–7) The CoCl2 may not be enough to quench cytosolic fluorescence. We need to increase the amount of CoCl2.

Problem 4

Cell aggregation occurs when cells were added into dish (step 2). Add the cells directly into dish without dilution will cause cell aggregation. We need to dilute the cells to 1 mL medium, mix well, add the cells into the dish, and then shake them gently.

Problem 5

The sorted cells have low survival rates (steps 12–14) Suspend MEFs to 2% FBS (Industria Argentina, NTC-HK008) instead of BSA in DPBS buffer before sorting the high and low mPTP opening cells.

Resource availability

Lead contact

Further information and requests for resources and reagents should be directed to and will be fulfilled by the lead contact, Xingguo Liu (liu_xingguo@gibh.ac.cn).

Materials availability

This study did not generate new unique reagents.

Data and code availability

This study did not generate/analyze new datasets/code.

Fibroblast medium

ReagentFinal concentrationAmount
DMEMn/a500 mL
FBS (Industria Argentina, NTC-HK008)10%56 mL
GlutaMAX1%5.6 mL
NEAA1%5.6 mL
Totaln/a567.2 mL

Mouse embryonic stem cells (mES) medium

ReagentFinal concentrationAmount
DMEMn/a500 mL
FBS (Gibco, 10099–141)15%93 mL
GlutaMAX1%6.2 mL
NEAA1%6.2 mL
sodium pyruvate1%6.2 mL
2-mercaptoethanol0.18%1127 μL
penicillin/streptomycin0.5%3.1 mL
mouse LIF10 ng/mL83 μL
Totaln/a615.91 mL
REAGENT or RESOURCESOURCEIDENTIFIER
Chemicals, peptides, and recombinant proteins

Hoechst 33342Thermo FisherCat# H3570
Bovine Serum Albumin (BSA)SigmaCat#B2064-50G
Modified HBSS bufferThermo FisherCat#14175095
Dulbecco's Phosphate-buffered saline (DPBS)GibcoCat#14190144
DMEM-Dulbecco’s Modified Eagle’s Medium, High GlucoseHyCloneCat#SH30022-2B
Fetal bovine serum (FBS)Industria ArgentinaCat#NTC-HK008
FBSGibcoCat#10099–141
GlutaMAXGibcoCat#35050–061
NEAAGibcoCat#11140–050
Sodium PyruvateGibcoCat#11360–070
MercaptoethanolThermo FisherCat#21985–023,
Penicillin/streptomycinHyCloneCat#SV30010
Mouse LIFMilliporeCat#LIF2050
EmbryoMax 0.1% Gelatin SolutionSigmaCat#ES-006-B
Optimized mediumGibcoCat#31985-070
PEIPolysciencesCat#23966

Experimental models: Cell lines

OG2 mouse embryonic fibroblasts:CBA/CaJ x C57BL/6JThis studyN/A
Platinum-E (Plat-E)A gift from the Fourth Military Medical UniversityN/A

Critical commercial assays

Transition Pore Assay KitThermo FisherCat# I35103

Recombinant DNA

pMXs-Oct3/4(Takahashi and Yamanaka, 2006)Addgene Cat#13366
pMXs-Sox2(Takahashi and Yamanaka, 2006)Addgene Cat#13367
pMXs-Klf4(Takahashi and Yamanaka, 2006)Addgene Cat#13370
pMXs-c-Myc(Takahashi and Yamanaka, 2006)Addgene Cat#13375

Other

35-mm DishSorfa Life Science201100
60-mm DishGreiner Bio-One628160
12-Well plateGreiner Bio-One665180
15-mL Centrifuge tubeCorning430790
1.5 mL Microcentrifuge TubeAxygenMCT-150-C
0.22-μm Sterflip filterMilliporeCat# SLGP033RB
0.45-μm Sterflip filterMilliporeCat# SLHVR33RB
Zeiss LSM 710 confocal laser scanning microscopeZeisshttps://www.zeiss.com/microscopy/int/software-cameras.html
MoFlo AstriosBeckman Coulterhttp://www.beckmancoulter.cn/ls-discovery/flow.aspx

Labeling solution

ReagentFinal concentrationAmount
modified HBSS buffern/a997 μL
calcein-AM1 μM1 μL
CoCl21 mM1 μL
Hoechst1 μM1 μL
Totaln/a1 mL
  7 in total

1.  A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts.

Authors:  Ronghui Li; Jialiang Liang; Su Ni; Ting Zhou; Xiaobing Qing; Huapeng Li; Wenzhi He; Jiekai Chen; Feng Li; Qiang Zhuang; Baoming Qin; Jianyong Xu; Wen Li; Jiayin Yang; Yi Gan; Dajiang Qin; Shipeng Feng; Hong Song; Dongshan Yang; Biliang Zhang; Lingwen Zeng; Liangxue Lai; Miguel Angel Esteban; Duanqing Pei
Journal:  Cell Stem Cell       Date:  2010-06-17       Impact factor: 24.633

Review 2.  The mitochondrial permeability transition pore and its involvement in cell death and in disease pathogenesis.

Authors:  Andrea Rasola; Paolo Bernardi
Journal:  Apoptosis       Date:  2007-05       Impact factor: 4.677

3.  Tet and TDG mediate DNA demethylation essential for mesenchymal-to-epithelial transition in somatic cell reprogramming.

Authors:  Xiao Hu; Lei Zhang; Shi-Qing Mao; Zheng Li; Jiekai Chen; Run-Rui Zhang; Hai-Ping Wu; Juan Gao; Fan Guo; Wei Liu; Gui-Fang Xu; Hai-Qiang Dai; Yujiang Geno Shi; Xianlong Li; Boqiang Hu; Fuchou Tang; Duanqing Pei; Guo-Liang Xu
Journal:  Cell Stem Cell       Date:  2014-02-13       Impact factor: 24.633

4.  Short-Term Mitochondrial Permeability Transition Pore Opening Modulates Histone Lysine Methylation at the Early Phase of Somatic Cell Reprogramming.

Authors:  Zhongfu Ying; Ge Xiang; Lingjun Zheng; Haite Tang; Lifan Duan; Xiaobing Lin; Qiuge Zhao; Keshi Chen; Yi Wu; Guangsuo Xing; Yiwang Lv; Linpeng Li; Liang Yang; Feixiang Bao; Qi Long; Yanshuang Zhou; Xueying He; Yaofeng Wang; Minghui Gao; Duanqing Pei; Wai-Yee Chan; Xingguo Liu
Journal:  Cell Metab       Date:  2018-08-30       Impact factor: 27.287

5.  Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

Authors:  Kazutoshi Takahashi; Shinya Yamanaka
Journal:  Cell       Date:  2006-08-10       Impact factor: 41.582

6.  Transient Activation of Mitoflashes Modulates Nanog at the Early Phase of Somatic Cell Reprogramming.

Authors:  Zhongfu Ying; Keshi Chen; Lingjun Zheng; Yi Wu; Linpeng Li; Rui Wang; Qi Long; Liang Yang; Jingyi Guo; Deyang Yao; Yong Li; Feixiang Bao; Ge Xiang; Jinglei Liu; Qiaoying Huang; Zhiming Wu; Andrew Paul Hutchins; Duanqing Pei; Xingguo Liu
Journal:  Cell Metab       Date:  2015-11-05       Impact factor: 27.287

7.  Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition).

Authors:  Andrea Cossarizza; Hyun-Dong Chang; Andreas Radbruch; Andreas Acs; Dieter Adam; Sabine Adam-Klages; William W Agace; Nima Aghaeepour; Mübeccel Akdis; Matthieu Allez; Larissa Nogueira Almeida; Giorgia Alvisi; Graham Anderson; Immanuel Andrä; Francesco Annunziato; Achille Anselmo; Petra Bacher; Cosima T Baldari; Sudipto Bari; Vincenzo Barnaba; Joana Barros-Martins; Luca Battistini; Wolfgang Bauer; Sabine Baumgart; Nicole Baumgarth; Dirk Baumjohann; Bianka Baying; Mary Bebawy; Burkhard Becher; Wolfgang Beisker; Vladimir Benes; Rudi Beyaert; Alfonso Blanco; Dominic A Boardman; Christian Bogdan; Jessica G Borger; Giovanna Borsellino; Philip E Boulais; Jolene A Bradford; Dirk Brenner; Ryan R Brinkman; Anna E S Brooks; Dirk H Busch; Martin Büscher; Timothy P Bushnell; Federica Calzetti; Garth Cameron; Ilenia Cammarata; Xuetao Cao; Susanna L Cardell; Stefano Casola; Marco A Cassatella; Andrea Cavani; Antonio Celada; Lucienne Chatenoud; Pratip K Chattopadhyay; Sue Chow; Eleni Christakou; Luka Čičin-Šain; Mario Clerici; Federico S Colombo; Laura Cook; Anne Cooke; Andrea M Cooper; Alexandra J Corbett; Antonio Cosma; Lorenzo Cosmi; Pierre G Coulie; Ana Cumano; Ljiljana Cvetkovic; Van Duc Dang; Chantip Dang-Heine; Martin S Davey; Derek Davies; Sara De Biasi; Genny Del Zotto; Gelo Victoriano Dela Cruz; Michael Delacher; Silvia Della Bella; Paolo Dellabona; Günnur Deniz; Mark Dessing; James P Di Santo; Andreas Diefenbach; Francesco Dieli; Andreas Dolf; Thomas Dörner; Regine J Dress; Diana Dudziak; Michael Dustin; Charles-Antoine Dutertre; Friederike Ebner; Sidonia B G Eckle; Matthias Edinger; Pascale Eede; Götz R A Ehrhardt; Marcus Eich; Pablo Engel; Britta Engelhardt; Anna Erdei; Charlotte Esser; Bart Everts; Maximilien Evrard; Christine S Falk; Todd A Fehniger; Mar Felipo-Benavent; Helen Ferry; Markus Feuerer; Andrew Filby; Kata Filkor; Simon Fillatreau; Marie Follo; Irmgard Förster; John Foster; Gemma A Foulds; Britta Frehse; Paul S Frenette; Stefan Frischbutter; Wolfgang Fritzsche; David W Galbraith; Anastasia Gangaev; Natalio Garbi; Brice Gaudilliere; Ricardo T Gazzinelli; Jens Geginat; Wilhelm Gerner; Nicholas A Gherardin; Kamran Ghoreschi; Lara Gibellini; Florent Ginhoux; Keisuke Goda; Dale I Godfrey; Christoph Goettlinger; Jose M González-Navajas; Carl S Goodyear; Andrea Gori; Jane L Grogan; Daryl Grummitt; Andreas Grützkau; Claudia Haftmann; Jonas Hahn; Hamida Hammad; Günter Hämmerling; Leo Hansmann; Goran Hansson; Christopher M Harpur; Susanne Hartmann; Andrea Hauser; Anja E Hauser; David L Haviland; David Hedley; Daniela C Hernández; Guadalupe Herrera; Martin Herrmann; Christoph Hess; Thomas Höfer; Petra Hoffmann; Kristin Hogquist; Tristan Holland; Thomas Höllt; Rikard Holmdahl; Pleun Hombrink; Jessica P Houston; Bimba F Hoyer; Bo Huang; Fang-Ping Huang; Johanna E Huber; Jochen Huehn; Michael Hundemer; Christopher A Hunter; William Y K Hwang; Anna Iannone; Florian Ingelfinger; Sabine M Ivison; Hans-Martin Jäck; Peter K Jani; Beatriz Jávega; Stipan Jonjic; Toralf Kaiser; Tomas Kalina; Thomas Kamradt; Stefan H E Kaufmann; Baerbel Keller; Steven L C Ketelaars; Ahad Khalilnezhad; Srijit Khan; Jan Kisielow; Paul Klenerman; Jasmin Knopf; Hui-Fern Koay; Katja Kobow; Jay K Kolls; Wan Ting Kong; Manfred Kopf; Thomas Korn; Katharina Kriegsmann; Hendy Kristyanto; Thomas Kroneis; Andreas Krueger; Jenny Kühne; Christian Kukat; Désirée Kunkel; Heike Kunze-Schumacher; Tomohiro Kurosaki; Christian Kurts; Pia Kvistborg; Immanuel Kwok; Jonathan Landry; Olivier Lantz; Paola Lanuti; Francesca LaRosa; Agnès Lehuen; Salomé LeibundGut-Landmann; Michael D Leipold; Leslie Y T Leung; Megan K Levings; Andreia C Lino; Francesco Liotta; Virginia Litwin; Yanling Liu; Hans-Gustaf Ljunggren; Michael Lohoff; Giovanna Lombardi; Lilly Lopez; Miguel López-Botet; Amy E Lovett-Racke; Erik Lubberts; Herve Luche; Burkhard Ludewig; Enrico Lugli; Sebastian Lunemann; Holden T Maecker; Laura Maggi; Orla Maguire; Florian Mair; Kerstin H Mair; Alberto Mantovani; Rudolf A Manz; Aaron J Marshall; Alicia Martínez-Romero; Glòria Martrus; Ivana Marventano; Wlodzimierz Maslinski; Giuseppe Matarese; Anna Vittoria Mattioli; Christian Maueröder; Alessio Mazzoni; James McCluskey; Mairi McGrath; Helen M McGuire; Iain B McInnes; Henrik E Mei; Fritz Melchers; Susanne Melzer; Dirk Mielenz; Stephen D Miller; Kingston H G Mills; Hans Minderman; Jenny Mjösberg; Jonni Moore; Barry Moran; Lorenzo Moretta; Tim R Mosmann; Susann Müller; Gabriele Multhoff; Luis Enrique Muñoz; Christian Münz; Toshinori Nakayama; Milena Nasi; Katrin Neumann; Lai Guan Ng; Antonia Niedobitek; Sussan Nourshargh; Gabriel Núñez; José-Enrique O'Connor; Aaron Ochel; Anna Oja; Diana Ordonez; Alberto Orfao; Eva Orlowski-Oliver; Wenjun Ouyang; Annette Oxenius; Raghavendra Palankar; Isabel Panse; Kovit Pattanapanyasat; Malte Paulsen; Dinko Pavlinic; Livius Penter; Pärt Peterson; Christian Peth; Jordi Petriz; Federica Piancone; Winfried F Pickl; Silvia Piconese; Marcello Pinti; A Graham Pockley; Malgorzata Justyna Podolska; Zhiyong Poon; Katharina Pracht; Immo Prinz; Carlo E M Pucillo; Sally A Quataert; Linda Quatrini; Kylie M Quinn; Helena Radbruch; Tim R D J Radstake; Susann Rahmig; Hans-Peter Rahn; Bartek Rajwa; Gevitha Ravichandran; Yotam Raz; Jonathan A Rebhahn; Diether Recktenwald; Dorothea Reimer; Caetano Reis e Sousa; Ester B M Remmerswaal; Lisa Richter; Laura G Rico; Andy Riddell; Aja M Rieger; J Paul Robinson; Chiara Romagnani; Anna Rubartelli; Jürgen Ruland; Armin Saalmüller; Yvan Saeys; Takashi Saito; Shimon Sakaguchi; Francisco Sala-de-Oyanguren; Yvonne Samstag; Sharon Sanderson; Inga Sandrock; Angela Santoni; Ramon Bellmàs Sanz; Marina Saresella; Catherine Sautes-Fridman; Birgit Sawitzki; Linda Schadt; Alexander Scheffold; Hans U Scherer; Matthias Schiemann; Frank A Schildberg; Esther Schimisky; Andreas Schlitzer; Josephine Schlosser; Stephan Schmid; Steffen Schmitt; Kilian Schober; Daniel Schraivogel; Wolfgang Schuh; Thomas Schüler; Reiner Schulte; Axel Ronald Schulz; Sebastian R Schulz; Cristiano Scottá; Daniel Scott-Algara; David P Sester; T Vincent Shankey; Bruno Silva-Santos; Anna Katharina Simon; Katarzyna M Sitnik; Silvano Sozzani; Daniel E Speiser; Josef Spidlen; Anders Stahlberg; Alan M Stall; Natalie Stanley; Regina Stark; Christina Stehle; Tobit Steinmetz; Hannes Stockinger; Yousuke Takahama; Kiyoshi Takeda; Leonard Tan; Attila Tárnok; Gisa Tiegs; Gergely Toldi; Julia Tornack; Elisabetta Traggiai; Mohamed Trebak; Timothy I M Tree; Joe Trotter; John Trowsdale; Maria Tsoumakidou; Henning Ulrich; Sophia Urbanczyk; Willem van de Veen; Maries van den Broek; Edwin van der Pol; Sofie Van Gassen; Gert Van Isterdael; René A W van Lier; Marc Veldhoen; Salvador Vento-Asturias; Paulo Vieira; David Voehringer; Hans-Dieter Volk; Anouk von Borstel; Konrad von Volkmann; Ari Waisman; Rachael V Walker; Paul K Wallace; Sa A Wang; Xin M Wang; Michael D Ward; Kirsten A Ward-Hartstonge; Klaus Warnatz; Gary Warnes; Sarah Warth; Claudia Waskow; James V Watson; Carsten Watzl; Leonie Wegener; Thomas Weisenburger; Annika Wiedemann; Jürgen Wienands; Anneke Wilharm; Robert John Wilkinson; Gerald Willimsky; James B Wing; Rieke Winkelmann; Thomas H Winkler; Oliver F Wirz; Alicia Wong; Peter Wurst; Jennie H M Yang; Juhao Yang; Maria Yazdanbakhsh; Liping Yu; Alice Yue; Hanlin Zhang; Yi Zhao; Susanne Maria Ziegler; Christina Zielinski; Jakob Zimmermann; Arturo Zychlinsky
Journal:  Eur J Immunol       Date:  2019-10       Impact factor: 6.688

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.